Toxoplasma pneumonia & parasitic pulmonary infections in HIV
Opportunistic infection · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Pulmonary toxoplasmosis is the 2nd most common manifestation of disseminated toxoplasmosis in AIDS (after encephalitis), CD4 typically <100. Presents as fever, non-productive cough and dyspnoea and mimics PCP. Also consider Strongyloides hyperinfection in patients from endemic areas, especially if steroid-exposed.
Red flags
- Hypoxia / respiratory failure / ARDS
- Extreme LDH elevation
- Concurrent CNS toxoplasmosis (headache, focal deficit, seizure)
- Disseminated disease / sepsis / multi-organ involvement
- Strongyloides hyperinfection with gram-negative sepsis or haemorrhage
Assessment
Differential diagnosis
- Pneumocystis jirovecii pneumonia (PCP)
- Tuberculosis
- Cryptococcal pneumonia
- Histoplasmosis
- Bacterial pneumonia
- Pulmonary Kaposi sarcoma
- Strongyloides hyperinfection
- CMV pneumonitis
Investigations
- CXR (diffuse bilateral interstitial/alveolar infiltrates; can be nodular/cavitary/lobar/effusion)
- Serum LDH - markedly/extremely elevated (more than in PCP)
- Toxoplasma gondii IgG (absence makes it unlikely)
- CD4 count
- BAL with Giemsa/methylene-blue stain for tachyzoites (crescent-shaped, 5-7 microns) + PCR
- Strongyloides serology/stool in endemic areas
Management
- In advanced HIV (CD4 <100) with fever + respiratory symptoms, consider toxoplasma pneumonitis alongside PCP/TB
- Check Toxoplasma IgG + serum LDH
- Obtain BAL for definitive diagnosis (tachyzoites/PCR)
- Oxygen and supportive care; manage respiratory failure
- Treat with pyrimethamine + sulfadiazine + leucovorin (same as encephalitis), or TMP-SMX if pyrimethamine unavailable
- Start/optimise ART (within ~2 weeks of diagnosis in treatment-naive)
- In endemic/steroid-exposed patients, consider and treat Strongyloides hyperinfection
Drugs & doses
Pyrimethamine + sulfadiazine + leucovorin (folinic acid) - regimen of choice (same as cerebral toxoplasmosis), ~3-6 weeks induction then maintenance/secondary prophylaxis - specific mg doses NOT given in this source (use standard toxoplasmosis dosing; flag)
TMP-SMX (co-trimoxazole) - alternative where pyrimethamine unavailable
Supportive: oxygen, treat respiratory failure
Strongyloides hyperinfection (endemic areas): ivermectin per Strongyloides protocol
Disposition
Admit (hypoxia, diagnostic uncertainty, IV therapy); ID + HIV team; BAL for diagnosis; start ART within ~2 weeks.
Complications & pitfalls
- Respiratory failure / ARDS
- Disseminated toxoplasmosis
- Concurrent toxoplasma encephalitis
- Strongyloides hyperinfection syndrome
- IRIS
Exam pearls
- Markedly elevated LDH + positive Toxoplasma IgG + diffuse infiltrates in CD4 <100 suggests toxoplasma pneumonitis - it mimics PCP; BAL distinguishes
- A negative Toxoplasma IgG makes pulmonary toxoplasmosis unlikely
- Screen for and empirically treat Strongyloides before giving steroids in patients from endemic areas
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.